| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/26/2005 | EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 10/26/2005 | EP1588717A1 PEG-LHRH analog conjugates |
| 10/26/2005 | EP1588716A1 Peg-urate oxidase conjugates and use thereof |
| 10/26/2005 | EP1588715A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 10/26/2005 | EP1588707A1 Stable solid medicinal composition for oral administration |
| 10/26/2005 | EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors. |
| 10/26/2005 | EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections |
| 10/26/2005 | EP1588701A2 Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities |
| 10/26/2005 | EP1588700A1 Biofunctional polymers prepared in supercritical fluid |
| 10/26/2005 | EP1588699A2 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 10/26/2005 | EP1588697A1 Emulsion gel for topical application of pharmaceuticals |
| 10/26/2005 | EP1588692A1 Durable foamed composition |
| 10/26/2005 | EP1588629A1 Matrix-forming composition containing pectin |
| 10/26/2005 | EP1588162A2 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 10/26/2005 | EP1587954A1 Solid surface for biomolecule delivery and high-throughput assay |
| 10/26/2005 | EP1587945A2 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 10/26/2005 | EP1587869A2 Membrane active polymers |
| 10/26/2005 | EP1587843A2 Combinatorial libraries of monomer domains |
| 10/26/2005 | EP1587550A2 Methods and compositions for administering therapeutic and diagnostic agents |
| 10/26/2005 | EP1587548A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection |
| 10/26/2005 | EP1587543A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 10/26/2005 | EP1587536A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 10/26/2005 | EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 10/26/2005 | EP1587524A2 Compositions and methods for targeted biological delivery of molecular carriers |
| 10/26/2005 | EP1587517A1 Anti-protozoal compositions comprising diclazuril |
| 10/26/2005 | EP1587484A2 Method of treating angiogenic tissue growth |
| 10/26/2005 | EP1587375A1 Novel compositions comprising carotenoids |
| 10/26/2005 | EP1534213A4 Water-based delivery systems |
| 10/26/2005 | EP1534072A4 Anthelmintic oral homogeneous veterinary pastes |
| 10/26/2005 | EP1463492B1 Adhesive and binding agent for dermal or transdermal treatment systems |
| 10/26/2005 | EP1444264A4 Methods and materials for targeting and affecting selected cells |
| 10/26/2005 | EP1423109B1 Compositions comprising pectin and ascorbic acid |
| 10/26/2005 | EP1397133B1 Rapid onset formulation |
| 10/26/2005 | EP1395224A4 Tamper resistant oral dosage form |
| 10/26/2005 | EP1368001B1 Pharmaceutical formulation comprising bicalutamide |
| 10/26/2005 | EP1365713B1 Urine incontinence device |
| 10/26/2005 | EP1361881B1 Steroid hormone products and methods for preparing them |
| 10/26/2005 | EP1280507B1 Eutectic mixtures in cosmetic compositions |
| 10/26/2005 | EP1265618B1 Anaesthetic compositions comprising alfaxalone |
| 10/26/2005 | EP1263392B1 Clear water-in-oil emulsions |
| 10/26/2005 | EP1212092B1 High viscosity liquid controlled delivery system and medical or surgical device |
| 10/26/2005 | EP1163234B1 Pharmaceutical formulations with improved aqueous solubility |
| 10/26/2005 | EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1 |
| 10/26/2005 | EP1107762B1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 10/26/2005 | EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 10/26/2005 | EP1082107B1 Controlled release lipoic acid |
| 10/26/2005 | EP1073415B1 Pharmaceutical compositions capable of being gelled |
| 10/26/2005 | EP0975357B1 Transdermal delivery system |
| 10/26/2005 | CN1688702A Use of recombinant measles viruses expressing epitopes of antigens of RNA viruses in the preparation of vaccine compositions |
| 10/26/2005 | CN1688572A Piperidinyl targeting compounds that selectively bind integrins |
| 10/26/2005 | CN1688529A Alkoxylates exhibiting low residual alcohol content |
| 10/26/2005 | CN1688345A Composition with stabilized redox properties and method of stabilization of redox properties |
| 10/26/2005 | CN1688343A Modified saccharides, conjugates thereof, and their manufacture |
| 10/26/2005 | CN1688321A Composition for treating hemorrhoids |
| 10/26/2005 | CN1688313A Orally dispersible pharmaceutical piribedil composition |
| 10/26/2005 | CN1688292A Taste masked dosage forms and processes for their preparation |
| 10/26/2005 | CN1688291A Immediate release dosage forms containing solid drug dispersions |
| 10/26/2005 | CN1688270A Topical patch and reagent kit containing a delayed-type hypersensitivity inducer |
| 10/26/2005 | CN1687118A Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome |
| 10/26/2005 | CN1686562A Composition of transiron protein and biological reducing agent and its preparation method |
| 10/26/2005 | CN1686561A Modified natural polymer medical adjuvant, its preparation method and use |
| 10/26/2005 | CN1686560A Chitin tetra ammonium salt nano-particle, its preparation method and use |
| 10/26/2005 | CN1686559A Chitose composition for promoting medicine transfer through skin penetration and its use method |
| 10/26/2005 | CN1686558A Chromium supplementing agent using palygorskite or montmorillonite as carrier, its preparation and use method |
| 10/26/2005 | CN1686557A Calcium sulphate based embedded type local medicine releasing system and preparation method |
| 10/26/2005 | CN1686549A Medicinal composition for treating high blood pressure |
| 10/26/2005 | CN1224424C Thermosetting medical carrier composition with mucosa adsorption |
| 10/26/2005 | CN1224423C Pharmaceutical composition improved in peroral absorbability |
| 10/26/2005 | CN1224388C Modified prodrug forms of ap/amp |
| 10/26/2005 | CN1224381C Method for prepaing fast-dispersing dosage forms containing fish gelatin |
| 10/26/2005 | CN1224380C Method for reducing residual organic solvent in microparticles and use in preparation of medicine thereof |
| 10/26/2005 | CN1224379C Liquisolid system and method of preparing the same |
| 10/26/2005 | CN1224373C Method for preparing base oil for cosmetic |
| 10/25/2005 | US6958411 Antitumor agent; viricide |
| 10/25/2005 | US6958326 Estrogen complexes; stabilization |
| 10/25/2005 | US6958325 Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics |
| 10/25/2005 | US6958318 Recombinant bacterial cells for delivery of PNP to tumor cells |
| 10/25/2005 | US6958241 Liposomes with outer surfaces having an affinity moiety that binds to a biological therapy target surface, and a hydrophilic polymer coating reversibly conjugated to said moiety; e.g. polymyxin B conjugate liposome for septic shock |
| 10/25/2005 | US6958240 Inhibition of major groove DNA binding proteins by modified polyamides |
| 10/25/2005 | US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug |
| 10/25/2005 | US6958160 liposomes include diacylglycerol-PEG compounds; melting point below about 40 degrees C, and acyl chains greater than or equal to 14 carbons in length; use in drug delivery, diagnostics, cosmetics, cosmeceuticals and nutraceuticals |
| 10/25/2005 | US6958159 Pharmaceutical gel composition |
| 10/25/2005 | US6958158 Immune modulation device for use in animals |
| 10/25/2005 | US6958154 Tacky component of an adhesive, and a film-forming, non-tacky component that are immiscible with each other to undergo phase separation |
| 10/25/2005 | US6958153 topical formulation of azithromycin / clarithromycin macrocyclic lactone antibiotic or Tacrolimus/ Sirolimus immunosuppressive macrolide and permeation modulator; minimizes systemic exposure treating at site reduced side effects; scalp conditions |
| 10/25/2005 | US6958148 microparticle comprising active agent and polymer having transglutaminase substrate reactive groups, wherein reactive groups are surface available, and polymer comprises amino acids having at least three contiguous linked glutamines; drug delivery |
| 10/25/2005 | US6958143 Aftersmoking; converting nicotine to cotinine; discharing in urine |
| 10/25/2005 | US6958142 Nasal spray formulation and method |
| 10/25/2005 | CA2440764C Combination of brimonidine and timolol for topical ophthalmic use |
| 10/25/2005 | CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine |
| 10/25/2005 | CA2298238C Controlled release by extrusion of solid amorphous dispersions of drugs |
| 10/25/2005 | CA2227887C Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 10/25/2005 | CA2197865C Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 10/21/2005 | CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 10/21/2005 | CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia |
| 10/20/2005 | WO2005097871A1 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| 10/20/2005 | WO2005097869A1 Polymers comprising ion channel modulating compounds and uses thereof |
| 10/20/2005 | WO2005097677A1 Embolization |
| 10/20/2005 | WO2005097672A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 10/20/2005 | WO2005097225A1 New viscoelastic composition, method of use and package |